Paneth cells respond to inflammation and contribute to tissue regeneration by acquiring stem-like features through SCF/c-Kit signaling M Schmitt, M Schewe, A Sacchetti, D Feijtel, WS van de Geer, ... Cell reports 24 (9), 2312-2328. e7, 2018 | 205 | 2018 |
Evaluation of AXIN1 and AXIN2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines W Wang, P Liu, M Lavrijsen, S Li, R Zhang, S Li, WS van de Geer, ... Scientific Reports 11 (1), 7470, 2021 | 11 | 2021 |
Continued androgen signalling inhibition improves cabazitaxel efficacy in prostate cancer L Mout, ME van Royen, C de Ridder, D Stuurman, WS van de Geer, ... EBioMedicine 73, 2021 | 8 | 2021 |
CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue J van Riet, C Saha, N Strepis, RWW Brouwer, ES Martens-Uzunova, ... Communications Biology 5 (1), 338, 2022 | 7 | 2022 |
Paneth cells respond to inflammation and contribute to tissue regeneration by acquiring stem-like features through SCF/c-Kit signaling. Cell Rep. 2018; 24 (9): 2312–28 M Schmitt, M Schewe, A Sacchetti, D Feijtel, WS van de Geer, ... J. CELREP 85, 2018 | 7 | 2018 |
ProteoDisco: a flexible R approach to generate customized protein databases for extended search space of novel and variant proteins in proteogenomic studies WS van de Geer, J van Riet, HJG van de Werken Bioinformatics 38 (5), 1437-1439, 2022 | 4 | 2022 |
Landscape of driver gene events, biomarkers, and druggable targets identified by whole-genome sequencing of glioblastomas WS van de Geer, Y Hoogstrate, K Draaisma, PA Robe, S Bins, ... Neuro-Oncology Advances 4 (1), vdab177, 2022 | 4 | 2022 |
The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies K de Joode, WS van de Geer, G van Leenders, P Hamberg, ... Scientific reports 13 (1), 10720, 2023 | 1 | 2023 |
Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumors WS van de Geer, RHJ Mathijssen, J van Riet, N Steeghs, M Labots, ... Biomedicine & Pharmacotherapy 159, 114210, 2023 | 1 | 2023 |
31P Genomic landscape and actionable targets as identified by whole genome sequencing and RNA sequencing in patients with advanced renal cell carcinoma KD Joode, WS van de Geer, G van Leenders, P Hamberg, HM Westgeest, ... Annals of Oncology 32, S1386, 2021 | | 2021 |
Comprehensive pan-cancer analysis of somatic mutations in drug transporters to reveal acquired and intrinsic drug resistance in 3149 metastatic cancer patients S Bins, WS van de Geer, J van Riet, N Steeghs, HMW Verheul, ... Annals of Oncology 30, v28-v29, 2019 | | 2019 |